Bloomberg Anywhere Remote Login Bloomberg Terminal Request a Demo


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

September 04, 2015 12:26 AM ET


Company Overview of KaloBios Pharmaceuticals, Inc.

Key Executives for KaloBios Pharmaceuticals, Inc.

NameBoard RelationshipsTitleAge
Herbert C. Cross No RelationshipsInterim Chief Executive Officer, Interim President and Chief Financial Officer43
Ronald A. Martell 46 RelationshipsExecutive Chairman53
Charles J. Democko No RelationshipsSenior Vice President of Regulatory Affairs and Quality60

KaloBios Pharmaceuticals, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Ronald A. Martell 46 RelationshipsKaloBios Pharmaceuticals, Inc.53
James W. Larrick Ph.D. 42 RelationshipsKaloBios Pharmaceuticals, Inc.--
Raymond M. Withy Ph.D. 7 RelationshipsKaloBios Pharmaceuticals, Inc.60
Denise M. Gilbert Ph.D. 7 RelationshipsKaloBios Pharmaceuticals, Inc.57
Gary A. Lyons 36 RelationshipsRigel Pharmaceuticals, Inc.64
View All Board Members

KaloBios Pharmaceuticals, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
Audit Committee Ph.D.Denise M. Gilbert7 Relationships2 Executives
Compensation Committee Gary A. Lyons36 Relationships3 Executives
Nominating Committee Ph.D.Raymond M. Withy7 Relationships3 Executives
Corporate Governance Committee Ph.D.Raymond M. Withy7 Relationships3 Executives
Advisory Board Ph.D.James W. Larrick42 Relationships1 Executives
View Committee Details
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


  Industry Range
Not meaningful
Total Short Term Compensation
Not meaningful
Total Value of Options$340.0K
Compensation as of Fiscal Year 2014
KaloBios Pharmaceuticals, Inc. CEO Compensation
Industry Average


Composition of Suominen's Nomination Board
September 02, 2015 6:30 AM ET
Michael C Feenan Joins SCA as Vice President of Personal Care Business in North America
August 26, 2015 10:30 AM ET
Alissa Sears to Join Aunt Fannie's, Inc.'s Board of Advisors
August 24, 2015 1:22 PM ET
The National Detergent Co. SAOG Announces Board Changes
August 20, 2015 10:16 AM ET
Kimberly-Clark Corporation Announces Resignation of Linda Johnson Rice from the Board of Directors
August 18, 2015 8:42 PM ET

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact KaloBios Pharmaceuticals, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at